The SA Prostate Cancer Clinical Outcomes Database (PCCOD), established in 1998 is managed by a team at the Repatriation General Hospital (RGH). It is an ongoing collaborative venture of Flinders University, Repatriation General Hospital, Royal Adelaide (RAH), Queen Elizabeth (QEH), and the University of Adelaide.
The Database follows men with prostate cancer treated at the three major metropolitan hospitals: the Royal Adelaide Hospital, the Queen Elizabeth Hospital, and Flinders Medical Centre/Repatriation General Hospital. Patients followed at a number of private practices are also included.
What we measure
We collect PSA at diagnosis, diagnostic pathology including Gleason primary and secondary, clinical stage, treatment type and attributes and prostate pathology for radical prostatectomy patients. Patients complete an Expanded Prostate Cancer Index Composite questionnaire at baseline, 3, 6, 12months, 2 and 5 years.
Outcomes measured are biochemical recurrence, prostate-specific death and death from any cause, radical pathology and patient-reported symptoms.
Who can apply to use data
We welcome collaborations with individual clinicians, scientists and organisations with a focus on prostate cancer. All analyses undergo ethical consideration. Results are made available publicly through presentation and publication.
- Chair: Kim Moretti MBBS, FRACS (Urology)
- Deputy Chair: Kim Horsell MBBS, FRACS (Urology)
- Michael Chong MBBS, FRACS (Urology)
- Darren Foreman MBBS, FRACS (Urology)
- Jimmy Lam MBBS, FRACS (Urology)
- Peter Sutherland MBBS, FRACS (Urology)
- Martin Borg MD, FRANZCR
- Leigh Pretty MNg, Practice Manager/CNC Urology
- Kerri Beckmann member, MSc (Cancer Council SA)
- Jeff Roberts consumer, PCFA
Data Management Team
- Carole Pinnock AM, PhD, Executive officer
- Tina Kopsaftis BSc, Clinical Data Coordinator
- Scott Walsh BNg, Data Manager
- Chair: Martin Borg
- Grant Buchanan
- Kim Moretti
- Kerri Beckmann
- Michael Chong
- Darren Foreman
- Kym Horsell
Topics of previous presentations
Analyses, presentations over the previous 12 months
- Stromal but not epithelial androgen receptor level is associated with prostate cancer related death. Samarth Chopra, Damien leach, Eleanor F Need, Villis R. Marshall, Tina Kopsaftis, David Tamblyn, Carole Pinnock, Tony Thomas, Grant Buchanan. Abstract accepted as a moderated poster presentation at the AUA, May 2011, Washington DC, USA
- SA Prostate Cancer Clinical Outcomes Database: 2010 Update Carole Pinnock on behalf of SA Prostate Cancer Outcomes Database Steering Committee and Management Team. Abstract presented at the local USANZ meeting 11&12 September 2010
- Clinical Profile of Veterans and Non-Veterans diagnosed with Prostate Cancer in the South Australian Prostate Cancer Outcomes Database. Harbison, S. Chopra, C.Pinnock, T. Kopsaftis, S. Walsh. Abstract presented at the local USANZ meeting September 2010
- Poorly differentiated low PSA prostate cancer – how do these men perform? A JAY, C PINNOCK, D TAMBLYN, T KOPSAFTIS. Abstract presented at the national USANZ meeting in Christchurch New Zealand, February 2011, local USANZ meeting September 2010 (won St. Paul's ball Prize for Best Trainee Paper). Abstract submitted for presentation at the AUA 2011.
- Comparative analysis of predictive accuracy of risk assessment tools in Australian Prostate Cancer patients S CHOPRA, D TAMBLYN, Y CHANGHONG, C PINNOCK, T KOPSAFTIS, M KATTAN. Abstract presented at the national USANZ meeting in Christchurch New Zealand, February 2011, local USANZ meeting September 2010 (won prize for Best Paper) and submitted for presentation at the AUA 2011.
- Active Surveillance – can we reduce the rate of failure? S CHOPRA, M CHONG, D TAMBLYN, T KOPSAFTIS, C PINNOCK. Abstract presented at the national USANZ meeting in Christchurch New Zealand, February 2011, local USANZ meeting September 2010. Abstract accepted as a moderated poster presentation at the AUA, May 2011, Washington DC, USA.
- Update on the current status of prostate cancer clinical outcomes database (PCCOD); recent analyses, presentations and publications, research summary for 2009; Future directions for 2010 and beyond. Sam Chopra, David Tamblyn, Carole Pinnock, Tina Kopsaftis: Presented at the weekly Thursday urology meeting on 17/12/09 at RGH.
- Is peri neural invasion in prostate biopsy predictive of cancer recurrence Post-radical prostatectomy? S Chopra, C Pinnock, D Tamblyn, T Kopsaftis, P Sutherland (moderated poster presentation at the EAU meeting in Barcelona April 2010, podium presentation at USANZ, national meeting in Perth, February 2010. Pilot Data presented by Bax, K. and Fuller, A. at local USANZ 2009 meeting.
- International validation of the CAPRA Score for predicting recurrence following radical prostatectomy: results from an Australian cohort. S Chopra, C Pinnock, D Tamblyn, T Kopsaftis, A Esterman, P Sutherland (moderated poster presentation at the EAU meeting in Barcelona April 2010, podium presentation at USANZ, in Perth February 2010 and podium presentation at AUA, in San Francisco, May 29-June 3, 2010. Paper submitted to BJUI December 2009, Paper submitted to The Journal of Urology October 10.
- External Validation of CAPRA Score amongst Radical Prostatectomy Patients from the Prostate Cancer Clinical Outcomes Database S Chopra, C Pinnock, D Tamblyn, T Kopsaftis, P Sutherland (USANZ national meeting in Perth, February 2010).